Researchers have developed a novel digital cognitive testing platform, using the Oxford Cognitive Testing Portal, that correlates with serological biomarkers to accurately measure cognitive impairment in Alzheimer’s patients. The study highlights the platform’s effectiveness in capturing subtle signs of impairment, potentially revolutionizing early diagnosis and tracking of Alzheimer’s disease.
CHEST wins $100,000 grant to improve diagnostic excellence in interstitial lung disease
The American College of Chest Physicians (CHEST) was awarded a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to improve diagnostic excellence in
December 22, 2023